-
Mashup Score: 5
Dr. Furqan shared data from a retrospective analysis on patients who received pirtobrutinib prior to CAR T-cell therapy.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
Blood Cancers Today
Oncology / HematologyBlood Cancers Today is a property that provides hematologists and oncologists with news, education, and information relevant to their patients and practices, with insight from experts in the field. As the online home of the publication, bloodcancerstoday.com is updated daily, with the most current information from around the specialty and multimedia content, including exclusive interviews with presenters at major medical meetings.
-
Mashup Score: 7
Dr. Garcia-Manero discussed the phase II ASTREON trial on myelodysplastic syndromes at the 2024 ASCO Annual Meeting.
Source: bloodcancerstoday.comCategories: General Medicine News, Onc News and JournalsTweet-
🙌 Dr. Guillermo Garcia-Manero, of @MDAndersonNews, discussed the phase II ASTREON trial on #MDS at #ASCO24! ➡️ Hear what he has to say: https://t.co/HTh2rDFM0s https://t.co/ats9omIO7P
-
-
Mashup Score: 3Luspatercept Improves Anemia Metrics Across Myelofibrosis Cohorts | Blood Cancers Today - 1 year(s) ago
Treatment with luspatercept improved transfusion burden and anemia across four cohorts of patients with myelofibrosis.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
Luspatercept improved transfusion burden and anemia across four cohorts of patients with #myelofibrosis. Read more about the report led by @AaronGerds, of @caseccc, and published in @BloodAdvances. 📰 https://t.co/ycS27PRudS https://t.co/23ca1VN8dl
-
At #ASCO24, @FateehaFurqan, a third-year oncology fellow at @MedicalCollege @MCWCancerCenter, shared data from a retrospective analysis on 11 patients who received pirtobrutinib prior to CAR-T therapy. #CLL 📺 Watch the full interview here! https://t.co/45CrOMx0Y8 https://t.co/HDdiUmgviP